FindTrial
Sign In

Application of ultrasound to look for muscle changes in type II diabetes

APPLICATION OF MUSCLE ULTRASONOGRAPHY TO ASSESS MUSCLE AND NERVE CHANGES OF THE LOWER LIMB IN TYPE II DIABETES MELLITUS WITH PERIPHERAL NEUROPATHY

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/11/038116
Enrollment
172
Registered
2021-11-18
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M00-M99- Diseases of the musculoskeletal system and connective tissue

Interventions

None listed

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: •Participants with Type II diabetes mellitus with and without peripheral neuropathy

Exclusion criteria

Exclusion criteria: 1. Participants with Type I diabetes 2. Participants with diabetic foot ulcer 3. Participants with fracture and implant in the lower limb 4. Participants with history of any surgery on lower limb or amputation 5. Participants with neurological issues 6. Renal dysfunction 7. History of thyroid or adrenal diseases 8. Subjects with history of cerebrovascular accident 9. Subjects with arthritic conditions

Design outcomes

Primary

MeasureTime frame
ultrasonography of skeletal muscle can be used as an efficient and cost effective diagnostic tool to rule out muscle mass loss in DPNTimepoint: 24 Months—

Secondary

MeasureTime frame
To establish and validate the reference range for measuring lower limb muscle mass changes in diabetic peripheral neuropathy using ultrasoundTimepoint: 36 Months—

Countries

India

Contacts

Public ContactDr Rajagopal K V

Manipal College of Health Professions

sharath.s@manipal.edu9483275486

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026